Seed Round

A new five-year partnership seeks to bridge the gap between clinical insight and investment, speeding up patient access to new medical technologies.

A $10T wave of business sales is coming. A new partnership aims to de-risk these deals for everyday entrepreneurs with insurance once reserved for Wall Street.

With a €1.4M EU grant, a Lithuanian startup launches AI tools to combat failed payments and empower fintech innovation across Europe.

AI Council 2026 reveals the industry's next chapter: European founders are flocking to SF, engineering is being reinvented, and video is set to break everything.

A Silicon Valley firm's new patent could end reactive cybersecurity by translating raw data into meaningful, predictive intelligence for AI systems.

With gonorrhea becoming increasingly resistant to antibiotics, a new $2.6M grant fuels the development of a promising preventative vaccine platform.

A Calgary startup's revolutionary wound care gel, already used in hospitals, is now being funded by the government for battlefield trauma applications.

A medtech startup received a major NIH award to develop a wearable AI that predicts SUDEP, a deadly complication of epilepsy, offering new hope for patients.

After a $700M exit with Peakon and leading a space-tech venture, serial entrepreneur Phil Chambers brings deep operational expertise to Balderton.

For the 5th straight year, WA's life sciences outpace job growth. See how AI leadership and strategic investment fuel its $43.4B economic impact.

HCL Group and the WEF's UpLink are seeking innovators to solve the global water crisis with a new challenge aimed at transforming our future water systems.

With a seasoned dealmaker at the helm, Elkedonia is advancing a first-in-class, non-hallucinogenic drug for depression targeting a novel protein.

The Chinese pharma giant's Q1 results reveal a successful pivot to innovation, with blockbuster deals and a strategic Nasdaq listing paving its global path.

Kensington Capital's sixth SPAC begins trading its warrants separately, signaling the next phase in its search for a high-growth automotive or AI company.

Harrington Discovery Institute opens its 2027 award call, offering millions in funding and expert support to turn academic research into life-saving medicines.

With backing from Mayo Clinic, a startup's AI promises to slash biomarker analysis from weeks to minutes, accelerating cancer care and drug discovery.

American Uranium secures over 1,000 acres at its Lo Herma project, bolstering domestic uranium resources amid a global nuclear energy resurgence.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

Geviti Health has launched a first-of-its-kind free AI platform to analyze bloodwork, promising to make preventative health more accessible than ever.

A Boston biotech says its new AI platform moves beyond correlation to find the true biological causes of disease, promising a new era for medicine.